These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6105352)

  • 1. Anti-asialo-GM1 antibody in sera from patients with Graves' disease and Hashimoto's thyroiditis.
    Sawada K; Sakurami T; Imura H; Iwamori M; Nabai Y
    Lancet; 1980 Jul; 2(8187):198. PubMed ID: 6105352
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis.
    Ariga T; Yoshida T; Mimori T; Yu RK
    Clin Exp Immunol; 1991 Dec; 86(3):483-8. PubMed ID: 1747956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior pituitary cell antibodies detected in Hashimoto's thyroiditis and Graves' disease.
    Kobayashi I; Inukai T; Takahashi M; Ishii A; Ohshima K; Mori M; Shimomura Y; Kobayashi S; Hashimoto A; Sugiura M
    Endocrinol Jpn; 1988 Oct; 35(5):705-8. PubMed ID: 3220050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.
    MacLean DB; Miller KB; Brown R; Reichlin S
    J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
    J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings].
    Konishi J; Grumet FC; Payne RO; Mori T; Kriss JP
    Diabete Metab; 1976 Sep; 2(3):163-4. PubMed ID: 1036991
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
    Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effect of cold agglutinins on lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis.
    Farid NR; Noel EP; Barnard JM; Marshall WH
    Cell Immunol; 1976 Mar; 22(2):394-8. PubMed ID: 946952
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease.
    Sikorska HM
    J Immunol; 1986 Dec; 137(12):3786-95. PubMed ID: 3782795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoantibody against Na+/I- symporter (NaIS)].
    Zeki K
    Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease.
    Nuovo JA; Baker JR; Wartofsky L; Lukes YG; Burman KD
    Diabetes; 1988 Mar; 37(3):317-20. PubMed ID: 3286332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HL-A antigens in Graves' disease and Hashimoto's thyroiditis.
    Farid NR; Barnard J; Kutas C; Noel EP; Marshall WH
    Int Arch Allergy Appl Immunol; 1975; 49(6):837-42. PubMed ID: 1242384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
    Romaldini JH; Werner MC; Rodrigues HF; Teixeira VL; Werner RS; Farah CS; Bromberg N
    J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetics of Hashimoto's and Graves' diseases.
    Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro solubilization of deposits of IgG immune complexes by gamma-globulins in patients with Graves' disease, Graves' ophthalmopathy, pretibial myxoedema and Hashimoto's thyroiditis.
    Antonelli A; Palla R; Casarosa L; Alberti B; Saracino A; Baschieri L
    Pharmacol Res; 1992 Sep; 26 Suppl 2():170-1. PubMed ID: 1384020
    [No Abstract]   [Full Text] [Related]  

  • 19. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.